Summary of invasive pneumococcal disease burden among children in the Asia-Pacific region

Tzou Yien Lin, Nitin K. Shah, Dennis Brooks, Carmen S. Garcia

Research output: Contribution to journalReview article

30 Citations (Scopus)

Abstract

Invasive pneumococcal disease (IPD) burden is significant in the Asia-Pacific region. This review describes the epidemiology and Streptococcus pneumoniae (SP) serotype distribution of IPD in children in the Asia-Pacific region from studies published from 1999 to 2010. IPD incidence varies widely in Asia-Pacific countries depending on the method of surveillance, the population studied, and the time period. Incidences are highest for younger children, with rates near 100-200 cases per 100,000 children aged <1 or 2 years. Incidences of preventable disease are estimated to be 6-200 cases per 100,000. Heptavalent pneumococcal conjugate vaccine (PCV7) serotype coverage shows a very wide range over the Asia-Pacific region. Ten countries have high vaccine serotype coverage (>70%), and six countries have low vaccine serotype coverage (<50%). The majority of SP serotypes in children with IPD in most countries in the Asia-Pacific region are susceptible to penicillin (intermediate and resistant <50%); a few countries have SP serotypes with high level resistance to penicillin (intermediate and resistant >50%). Japan, Taiwan, and Thailand have high PCV7 serotype coverage. Countries with low pneumococcal resistance to antimicrobials have shown increasingly higher nonsusceptibility with time. National vaccination programmes that include PCV7, 10-valent pneumococcal conjugate vaccine (PCV), or 13-valent PCV would significantly affect IPD burden in children aged <5 years in the Asia-Pacific region, as well as the burden of penicillin-nonsusceptible IPD.

Original languageEnglish
Pages (from-to)7589-7605
Number of pages17
JournalVaccine
Volume28
Issue number48
DOIs
Publication statusPublished - Nov 10 2010
Externally publishedYes

Fingerprint

burden of disease
serotypes
vaccines
Streptococcus pneumoniae
Population Surveillance
penicillins
Conjugate Vaccines
disease incidence
Incidence
Thailand
epidemiology
Taiwan
anti-infective agents
Penicillins
vaccination
Japan
Vaccination
Epidemiology
incidence
Vaccines

Keywords

  • Asia-Pacific.
  • Pneumococcus
  • Vaccine

ASJC Scopus subject areas

  • Molecular Medicine
  • Immunology and Microbiology(all)
  • veterinary(all)
  • Public Health, Environmental and Occupational Health
  • Infectious Diseases

Cite this

Summary of invasive pneumococcal disease burden among children in the Asia-Pacific region. / Lin, Tzou Yien; Shah, Nitin K.; Brooks, Dennis; Garcia, Carmen S.

In: Vaccine, Vol. 28, No. 48, 10.11.2010, p. 7589-7605.

Research output: Contribution to journalReview article

Lin, Tzou Yien ; Shah, Nitin K. ; Brooks, Dennis ; Garcia, Carmen S. / Summary of invasive pneumococcal disease burden among children in the Asia-Pacific region. In: Vaccine. 2010 ; Vol. 28, No. 48. pp. 7589-7605.
@article{98b4d918804041459294474542ac09e0,
title = "Summary of invasive pneumococcal disease burden among children in the Asia-Pacific region",
abstract = "Invasive pneumococcal disease (IPD) burden is significant in the Asia-Pacific region. This review describes the epidemiology and Streptococcus pneumoniae (SP) serotype distribution of IPD in children in the Asia-Pacific region from studies published from 1999 to 2010. IPD incidence varies widely in Asia-Pacific countries depending on the method of surveillance, the population studied, and the time period. Incidences are highest for younger children, with rates near 100-200 cases per 100,000 children aged <1 or 2 years. Incidences of preventable disease are estimated to be 6-200 cases per 100,000. Heptavalent pneumococcal conjugate vaccine (PCV7) serotype coverage shows a very wide range over the Asia-Pacific region. Ten countries have high vaccine serotype coverage (>70{\%}), and six countries have low vaccine serotype coverage (<50{\%}). The majority of SP serotypes in children with IPD in most countries in the Asia-Pacific region are susceptible to penicillin (intermediate and resistant <50{\%}); a few countries have SP serotypes with high level resistance to penicillin (intermediate and resistant >50{\%}). Japan, Taiwan, and Thailand have high PCV7 serotype coverage. Countries with low pneumococcal resistance to antimicrobials have shown increasingly higher nonsusceptibility with time. National vaccination programmes that include PCV7, 10-valent pneumococcal conjugate vaccine (PCV), or 13-valent PCV would significantly affect IPD burden in children aged <5 years in the Asia-Pacific region, as well as the burden of penicillin-nonsusceptible IPD.",
keywords = "Asia-Pacific., Pneumococcus, Vaccine",
author = "Lin, {Tzou Yien} and Shah, {Nitin K.} and Dennis Brooks and Garcia, {Carmen S.}",
year = "2010",
month = "11",
day = "10",
doi = "10.1016/j.vaccine.2010.07.053",
language = "English",
volume = "28",
pages = "7589--7605",
journal = "Vaccine",
issn = "0264-410X",
publisher = "Elsevier BV",
number = "48",

}

TY - JOUR

T1 - Summary of invasive pneumococcal disease burden among children in the Asia-Pacific region

AU - Lin, Tzou Yien

AU - Shah, Nitin K.

AU - Brooks, Dennis

AU - Garcia, Carmen S.

PY - 2010/11/10

Y1 - 2010/11/10

N2 - Invasive pneumococcal disease (IPD) burden is significant in the Asia-Pacific region. This review describes the epidemiology and Streptococcus pneumoniae (SP) serotype distribution of IPD in children in the Asia-Pacific region from studies published from 1999 to 2010. IPD incidence varies widely in Asia-Pacific countries depending on the method of surveillance, the population studied, and the time period. Incidences are highest for younger children, with rates near 100-200 cases per 100,000 children aged <1 or 2 years. Incidences of preventable disease are estimated to be 6-200 cases per 100,000. Heptavalent pneumococcal conjugate vaccine (PCV7) serotype coverage shows a very wide range over the Asia-Pacific region. Ten countries have high vaccine serotype coverage (>70%), and six countries have low vaccine serotype coverage (<50%). The majority of SP serotypes in children with IPD in most countries in the Asia-Pacific region are susceptible to penicillin (intermediate and resistant <50%); a few countries have SP serotypes with high level resistance to penicillin (intermediate and resistant >50%). Japan, Taiwan, and Thailand have high PCV7 serotype coverage. Countries with low pneumococcal resistance to antimicrobials have shown increasingly higher nonsusceptibility with time. National vaccination programmes that include PCV7, 10-valent pneumococcal conjugate vaccine (PCV), or 13-valent PCV would significantly affect IPD burden in children aged <5 years in the Asia-Pacific region, as well as the burden of penicillin-nonsusceptible IPD.

AB - Invasive pneumococcal disease (IPD) burden is significant in the Asia-Pacific region. This review describes the epidemiology and Streptococcus pneumoniae (SP) serotype distribution of IPD in children in the Asia-Pacific region from studies published from 1999 to 2010. IPD incidence varies widely in Asia-Pacific countries depending on the method of surveillance, the population studied, and the time period. Incidences are highest for younger children, with rates near 100-200 cases per 100,000 children aged <1 or 2 years. Incidences of preventable disease are estimated to be 6-200 cases per 100,000. Heptavalent pneumococcal conjugate vaccine (PCV7) serotype coverage shows a very wide range over the Asia-Pacific region. Ten countries have high vaccine serotype coverage (>70%), and six countries have low vaccine serotype coverage (<50%). The majority of SP serotypes in children with IPD in most countries in the Asia-Pacific region are susceptible to penicillin (intermediate and resistant <50%); a few countries have SP serotypes with high level resistance to penicillin (intermediate and resistant >50%). Japan, Taiwan, and Thailand have high PCV7 serotype coverage. Countries with low pneumococcal resistance to antimicrobials have shown increasingly higher nonsusceptibility with time. National vaccination programmes that include PCV7, 10-valent pneumococcal conjugate vaccine (PCV), or 13-valent PCV would significantly affect IPD burden in children aged <5 years in the Asia-Pacific region, as well as the burden of penicillin-nonsusceptible IPD.

KW - Asia-Pacific.

KW - Pneumococcus

KW - Vaccine

UR - http://www.scopus.com/inward/record.url?scp=77956279934&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77956279934&partnerID=8YFLogxK

U2 - 10.1016/j.vaccine.2010.07.053

DO - 10.1016/j.vaccine.2010.07.053

M3 - Review article

C2 - 20674872

AN - SCOPUS:77956279934

VL - 28

SP - 7589

EP - 7605

JO - Vaccine

JF - Vaccine

SN - 0264-410X

IS - 48

ER -